[1]中华医学会肾脏病学分会专家组.终末期糖尿病肾脏病肾替代治疗的中国指南[J].中华肾脏病杂志, 2022, 38(1):62-75
[2]BOENINK R, STEL V S, WALDUM-GREVBO B E, et al.Data from the ERA-EDTA Registry were examined for trends in excess mortality in European adults on kidney replacement therapy[J]. Kidney Int, 2020, 98(4):999-1008
[3]CHEN J H, JOHNSON D W, WONG G, et al.Associations between diabetes and sex with peritoneal dialysis technique and patient survival: Results from the Australia and New Zealand Dialysis and Transplant Registry cohort study[J].Perit Dial Int, 2021, 41(1):57-68
[4]XIA X, QIU Y G, YU J, et al.Ten-year survival of patients treated with peritoneal dialysis: A prospective observational cohort study[J].Periton Dialysis Int, 2020, 40(6):573-80
[5]WIJEWICKRAMA P, ONYEMA M, EID H, et al.Standards of diabetes care and burden of hypoglycaemia in people with diabetes on peritoneal dialysis: Results from a real-world clinical audit[J].Perit Dial Int, 2023, 0(0):8968608231195492-
[6]CHENG H-T, XU X, LIM P S, et al.Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease,2000-2015[J].Diabetes Care, 2021, 44(1):89-97
[7]THAMER M, HWANG W, FINK N E, et al.US nephrologists' recommendation of dialysis modality: results of a national survey[J].American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation, 2000, 36(6):1155-65
[8]KARKAR A, WILKIE M.Peritoneal dialysis in the modern era[J].Perit Dial Int, 2023, 43(4):301-14
[9]UNITED STATES RENAL DATA SYSTEM.2022 USRDS Annual Data Report: Epidemiology of kidney disease in the United States [R]. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
[10]KRAMER A, BOENINK R, STEL V S, et al.The ERA-EDTA Registry Annual Report 2018: a summary[J].Clin Kidney J, 2021, 14(1):107-23
[11]WU H, LAU E S H, YANG A, et al.Trends in kidney failure and kidney replacement therapy in people with diabetes in Hong Kong, 2002-2015: A retrospective cohort study[J].Lancet Reg Health West Pac, 2021, 11:100165-
[12]LIU H, HE Z R, HU X X, et al.Propensity-matched comparison of mortality between peritoneal dialysis and hemodialysis in patients with type 2 diabetes[J].Int Urol Nephrol, 2022, 54(6):1373-81
[13]XU F, YANG Y, WU M, et al.Patients with end-stage renal disease and diabetes had similar survival rates whether they received hemodialysis or peritoneal dialysis[J].Ther Apher Dial, 2023, 27(1):59-65
[14]ELSAYED M E, MORRIS A D, LI X, et al.Propensity score matched mortality comparisons of peritoneal and in-centre haemodialysis: systematic review and meta-analysis[J].Nephrol Dial Transplant, 2020, 35(12):2172-82
[15]XU X-D, HAN X, YANG Y, et al.Comparative study on the efficacy of peritoneal dialysis and hemodialysis in patients with end-stage diabetic nephropathy[J].Pak J Med Sci, 2020, 36(7):1484-9
[16]WEI Z, JIN Y, CHENG J, et al.Chinese experience on comparison of clinical efficacy and safety of hemodialysis and peritoneal dialysis in the treatment of diabetic kidney failure: a systematic review and meta-analysis[J].Front Med (Lausanne), 2020, 10:1116103-
[17]CHEN X X, DUAN Y, ZHOU Y.Effects of Hemodialysis and Peritoneal Dialysis on Glycometabolism in Patients with End-Stage Diabetic Nephropathy[J].Blood Purificat, 2021, 50(4-5):506-12
[18]NG J K C, LING J M, LUK A O Y, et al.Evaluation of a Fourth-Generation Subcutaneous Real-Time Continuous Glucose Monitor (CGM) in Individuals With Diabetes on Peritoneal Dialysis[J].Diabetes Care, 2023, 46(6):1191-5
[19]HAYASHI A, SHIMIZU N, SUZUKI A, et al.Hemodialysis-Related Glycemic Disarray Proven by Continuous Glucose Monitoring; Glycemic Markers and Hypoglycemia[J].Diabetes Care, 2021, 44(7):1647-56
[20]白田丽 朱, 王云满, 吴歆韵, 王浩.腹膜透析治疗糖尿病肾脏疾病患者的临床现状分析[J].国际泌尿系统杂志, 2022, 42(4):761-764
[21]BROWN E A, ZHAO J H, MCCULLOUGH K, et al.Burden of Kidney Disease,Health-Related Quality of Life,and Employment Among Patients Receiving Peritoneal Dialysis and In-Center Hemodialysis: Findings From the DOPPS Program[J].Am J Kidney Dis, 2021, 78(4):489-U15
[22]MOK M M Y, LIU C K M, LAM M F, et al.A Longitudinal Study on the Prevalence and Risk Factors for Depression and Anxiety,Quality of Life,and Clinical Outcomes in Incident Peritoneal Dialysis Patients[J].Periton Dialysis Int, 2019, 39(1):74-82
[23]SZETO C C, CHOW K M, KWAN B C H, et al.New-onset hyperglycemia in nondiabetic Chinese patients started on peritoneal dialysis[J].Am J Kidney Dis, 2007, 49(4):524-32
[24]DUONG U, MEHROTRA R, MOLNAR M Z, et al.Glycemic Control and Survival in Peritoneal Dialysis Patients with Diabetes Mellitus[J].Clin J Am Soc Nephro, 2011, 6(5):1041-8
[25]RHEE C M, KOVESDY C P, RAVEL V A, et al.Association of Glycemic Status During Progression of Chronic Kidney Disease With Early Dialysis Mortality in Patients With Diabetes[J].Diabetes Care, 2017, 40(8):1050-7
[26]AFGHAHI H, NASIC S, PETERS B, et al.Long-term glycemic variability and the risk of mortality in diabetic patients receiving peritoneal dialysis [J].Plos One, 2022, 17(1):e0262880-
[27]RODRíGUEZ-CARMONA A, PéREZ-FONTáN M, LóPEZ-MU?IZ A, et al.Correlation between Glycemic Control and the Incidence of Peritoneal and Catheter Tunnel and Exit-Site Infections in Diabetic Patients Undergoing Peritoneal Dialysis[J].Periton Dialysis Int, 2014, 34(6):618-26
[28]REDDY Y N V, MENDU M L.The Role of Incremental Peritoneal Dialysis in the Era of the Advancing American Kidney Health Initiative[J].Clin J Am Soc Nephro, 2020, 15(12):1835-7
[29]BROWN E A, BLAKE P G, BOUDVILLE N, et al.International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis[J].Periton Dialysis Int, 2020, 40(3):244-53
[30]AUGUSTE B L, BARGMAN J M.Peritoneal Dialysis Prescription and Adequacy in Clinical Practice: Core Curriculum 2023[J].Am J Kidney Dis, 2023, 81(1):100-9
[31]HUANG L L, MAH J Y, HOWARD J, et al.Incremental peritoneal dialysis is a safe and feasible prescription in incident patients with preserved residual kidney function[J].Nephrology (Carlton) , 2022, 27(1):74-81
[32]LEE S M, MIN Y S, SON Y K, et al.Comparison of clinical outcome between incremental peritoneal dialysis and conventional peritoneal dialysis: a propensity score matching study[J].Renal Failure, 2021, 43(1):1222-8
[33]OBA I, MORI T, CHIDA M, et al.Glucose and Insulin Response to Peritoneal Dialysis Fluid in Diabetic and Nondiabetic Peritoneal Dialysis Patients [J].Advances In Peritoneal Dialysis, 2015, 31:11-6
[34]WEN Y Q, GUO Q Y, YANG X A, et al.High Glucose Concentrations in Peritoneal Dialysate Are Associated with All-Cause and Cardiovascular Disease Mortality in Continuous Ambulatory Peritoneal Dialysis Patients[J].Periton Dialysis Int, 2015, 35(1):70-7
[35]LAMBIE M, CHESS J, DO J Y, et al.Peritoneal Dialysate Glucose Load and Systemic Glucose Metabolism in Non-Diabetics: Results from the GLOBAL Fluid Cohort Study[J].Plos One, 2016, 11(6):e0155564-
[36]WANG A Y M, BRIMBLE K S, BRUNIER G, et al.ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part I - Assessment and Management of Various Cardiovascular Risk Factors[J].Periton Dialysis Int, 2015, 35(4):379-87
[37]GOOSSEN K, BECKER M, MARSHALL M R, et al.Icodextrin Versus Glucose Solutions for the Once-Daily Long Dwell in Peritoneal Dialysis: An Enriched Systematic Review and Meta-analysis of Randomized Controlled Trials[J].Am J Kidney Dis, 2020, 75(6):830-46
[38]TAKATORI Y, AKAGI S, SUGIYAMA H, et al.Icodextrin Increases Technique Survival Rate in Peritoneal Dialysis Patients with Diabetic Nephropathy by Improving Body Fluid Management: A Randomized Controlled Trial[J].Clin J Am Soc Nephro, 2011, 6(6):1337-44
[39]PANIAGUA R, VENTURA M, AVILA-DíAZ M, et al.Icodextrin Improves Metabolic and Fluid Management in High and High-Average Transport Diabetic Patients[J].Periton Dialysis Int, 2009, 29(4):422-32
[40]IYASERE O, NAGAR R, JESUS-SILVA J A, et al.The impact of amino acid dialysate on anthropometric measures in adult patients on peritoneal dialysis: A systematic review and meta-analysis[J].Periton Dialysis Int, 2022, 42(3):314-23
[41]LI P K T, CULLETON B F, ARIZA A, et al.Randomized,Controlled Trial of Glucose-Sparing Peritoneal Dialysis in Diabetic Patients[J].J Am Soc Nephrol, 2013, 24(11):1889-900
[42]ARFEEN S, GOODSHIP T H, KIRKWOOD A, et al.amino acid peritoneal dialysate: single-cycle study in diabetic patients with end-stage renal disease[J].American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation, 1994, 23(1):86-90
[43]DE BOER I H, ROSSING P.KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease[J].Kidney Int, 2020, 98(4S):S1-S115
[44]FREEDMAN B I, ANDRIES L, SHIHABI Z K, et al.Glycated Albumin and Risk of Death and Hospitalizations in Diabetic Dialysis Patients[J].Clin J Am Soc Nephro, 2011, 6(7):1635-43
[45]WATANABE Y, OHNO Y, INOUE T, et al.Blood glucose levels in peritoneal dialysis are better reflected by HbA1c than by glycated albumin[J].Adv Perit Dial, 2014, 30:75-82
[46]FREEDMAN B I, SHENOY R N, PLANER J A, et al.Comparison of Glycated Albumin and Hemoglobin a Concentrations in Diabetic Subjects on Peritoneal and Hemodialysis[J].Periton Dialysis Int, 2010, 30(1):72-9
[47]MARSHALL J, JENNINGS P, SCOTT A, et al.Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS)[J].Kidney Int, 2003, 64(4):1480-6
[48]ELSAYED N A, ALEPPO G, ARODA V R, et al.6. Glycemic Targets: Standards of Care in Diabetes-2023 [J].Diabetes Care, 2023, 46(Suppl 1):S97-S110
[49]LING J M, NG J K C, CHAN J C N, et al.Use of Continuous Glucose Monitoring in the Assessment and Management of Patients With Diabetes and Chronic Kidney Disease[J].Front Endocrinol, 2022, 13:869899-
[50]LI Y, XIE Q H, YOU H Z, et al.Twelve Weeks of Pioglitazone Therapy Significantly Attenuates Dysmetabolism and Reduces Inflammation in Continuous Ambulatory Peritoneal Dialysis Patients-a Randomized Crossover Trial[J].Periton Dialysis Int, 2012, 32(5):507-15
[51]BOMHOLT T, IDORN T, KNOP F K, et al.The Glycemic Effect of Liraglutide Evaluated by Continuous Glucose Monitoring in Persons with Type 2 Diabetes Receiving Dialysis[J].Nephron, 2021, 145(1):27-34
[52]BORKUM M, JAMAL A, SINGH R S, et al.The rationale for the need to study sodium-glucose co-transport 2 inhibitor usage in peritoneal dialysis patients[J].Periton Dialysis Int, 2023, 43(2):139-44
[53]徐焕焕, 马文明, 赵婷.腹膜透析时，胰岛素该怎么调整[J].中华糖尿病杂志, 2023, 15(1):76-81
[54]FRANKEL A H, WAHBA M, ASHWORTH V, et al.Management of adults with diabetes on dialysis: Summary of recommendations of the Joint British Diabetes Societies guidelines 2022 [J].Diabetic Med, 2023, 40(4):e15027-
[55]ZANCHI A, JEHLE A W, LAMINE F, et al.Diabetic kidney disease in type 2 diabetes: a consensus statement from the Swiss Societies of Diabetes and Nephrology[J].Swiss Med Wkly, 2023, 153:4004-
[56]ABE M, HAMANO T, HOSHINO J, et al.Glycemic control and survival in peritoneal dialysis patients with diabetes: A 2-year nationwide cohort study[J].Sci Rep-Uk, 2019, 9(1):3320-
[57]WIJEWICKRAMA P, WILLIAMS J, BAIN S, et al.Narrative Review of Glycemic Management in People With Diabetes on Peritoneal Dialysis[J].Kidney Int Rep, 2023, 8(4):700-14
[58]KIM Y-L.Can we overcome the predestined poor survival of diabetic patients? Perspectives from pre- and post-dialysis[J].Perit Dial Int, 2007, 27(Suppl 2):S171-5
[59]TANRIOVER C, UCKU D, BASILE C, et al.On the importance of the interplay of residual renal function with clinical outcomes in end-stage kidney disease[J].J Nephrol, 2022, 35(9):2191-204
[60]PANIAGUA R, GARCíA-LóPEZ E, áVILA-DíAZ M, et al.Sex Modulates Cardiovascular Effects of Icodextrin-Based Peritoneal Dialysis Solutions[J].Front Physiol, 2022, 13:911072-
[61]BANERJEE D, WINOCOUR P, CHOWDHURY T A, et al.Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021[J].BMC Nephrol, 2022, 23(1):9-40
[62]WEI X, WEN Y Q, ZHOU Q, et al.Hyperlipidemia and mortality associated with diabetes mellitus co-existence in Chinese peritoneal dialysis patients[J].Lipids Health Dis, 2020, 19(1):234-243
[63]GOLDFARB-RUMYANTZEV A S, HABIB A N, BAIRD B C, et al.The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis[J].Am J Kidney Dis, 2007, 50(5):791-802
[64]WONG T Y-H, SZETO C-C, CHOW K-M, et al.Rosiglitazone reduces insulin requirement and C-reactive protein levels in type 2 diabetic patients receiving peritoneal dialysis[J].American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation, 2005, 46(4):713-9
[65]LEE J E, OH K-H, CHOI K H, et al.Statin therapy is associated with improved survival in incident peritoneal dialysis patients: propensity-matched comparison[J].Nephrol Dial Transplant, 2011, 26(12):4090-4
[66]IKIZLER T A, BURROWES J D, BYHAM-GRAY L D, et al.KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update[J].Am J Kidney Dis, 2020, 76((3 Suppl 1)):S1-S107
[67]KIRAN V R, ZHU T Y, YIP T, et al.Body Mass Index and Mortality Risk in Asian Peritoneal Dialysis Patients in Hong Kong-Impact of Diabetes and Cardiovascular Disease Status[J].Periton Dialysis Int, 2014, 34(4):390-8
[68]OBI Y, STREJA E, MEHROTRA R, et al.Impact of Obesity on Modality Longevity,Residual Kidney Function,Peritonitis,and Survival Among Incident Peritoneal Dialysis Patients[J].Am J Kidney Dis, 2018, 71(6):802-13
[69]GRZYWACZ A, LUBAS A, SMOSZNA J, et al.Risk Factors Associated with All-Cause Death Among Dialysis Patients with Diabetes[J].Med Sci Monitor, 2021, 27:e930152-
[70]HSU C K, LEE C C, CHEN Y T, et al.Multidisciplinary predialysis education reduces incidence of peritonitis and subsequent death in peritoneal dialysis patients: 5-year cohort study [J].Plos One, 2018, 13(8):e0202781-
